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Abstract 
Bone growth on and into implants exhibiting substantial surface porosity is a promising strategy in 
order to improve the long-term stable fixation of bone implants. However, the reliability in clinical 
applications remains a point of discussion. Most attention has been dedicated to the role of 
macroporosity, leading to the general consensus of a minimal pore size of 50–100 μm in order to 
allow bone ingrowth. In this in vivo study, we assessed the feasibility of early bone ingrowth into a 
predominantly microporous Ti coating with an average thickness of 150 μm and the hypothesis of 
improving the bone response through surface modification of the porous coating. Implants were 
placed in the cortical bone of rabbit tibiae for periods of 2 and 4 weeks and evaluated histologically 
and histomorphometrically using light microscopy and scanning electron microscopy. Bone with 
osteocytes encased in the mineralized matrix was found throughout the porous Ti coating up to the 
coating/substrate interface, highlighting that osseointegration of microporosities (<10 μm) was 
achievable. The bone trabeculae interweaved with the pore struts, establishing a large contact area 
which might enable an improved load transfer and stronger implant/bone interface. Furthermore, 
there was a clear interconnection with the surrounding cortical bone, suggesting that mechanical 
interlocking of the coating in the host bone in the long term is possible. When surface modifications 
inside the porous structure further reduced the interconnective pore size to the submicrometer 
level, bone ingrowth was impaired. On the other hand, application of a sol–gel-derived bioactive 
glass–ceramic coating without altering the pore characteristics was found to significantly improve 
bone regeneration around the coating, while still supporting bone ingrowth. 
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1. Introduction 
Joint replacement and dental restoration have evolved enormously over the past decades, resulting 
in excellent clinical success rates. Ten-year survival rates up to 95.3% for hip implants and even 
98.8% for dental implants have been reported [1] and [2]. However, due to the ever-expanding 
demand for implants, an increasing number of patients still suffer from implant failure and, in 
addition, there is a trend towards a younger and more active patient population, which raises higher 
expectations regarding the durability and longevity of implants [3]. Maintaining a long-term stable 
fixation has become a key priority in implantology. In this regard, the concept of osseointegration 
gave rise to the development of cementless implants relying on a close implant/bone contact for a 
firm retention in the host bone. Although the first generation of cementless implants was not 
unambiguously successful, recent studies confirm a long-term survivorship for different cementless 
components comparable to their cemented counterparts [4] and [5]. 
Due to the outstanding mechanical properties such as a high strength and good fatigue resistance in 
combination with an excellent biocompatibility, titanium and Ti alloys have become the material of 
choice for load-bearing implant applications [6]. The stable oxide layer at the surface enables a close 
bone apposition, allowing successful osseointegration under appropriate conditions (implant surface, 
quality of the host bone, loading condition), but in order to improve outcomes in more challenging 
circumstances (e.g. compromised bone), further control of the bone formation is required. 
From a materials perspective, the implant surface determines the rate and extent of 
osseointegration. Therefore, extensive research efforts focused on modifying the bioinert Ti surface 
towards an improved osteoconductivity or even osteoinductivity in order to stimulate a more 
efficient peri-implant bone formation [7], [8] and [9]. In a first approach, the surface topography was 
altered either on a macro- and microscale by surface roughening techniques (e.g. sandblasting and 
acid-etching), as a higher roughness promoted implant stability through an increased friction force 
with the bone, or on a nanoscale in order to encourage bone cell interactions [10], [11] and [12]. 
Secondly, chemical modification of the surface (e.g. calcium phosphate (CaP) or biomolecule 
coatings) could mimic the natural bone interface and even stimulated bone regeneration 
[12] and [13]. 
Porous Ti coatings, generally applied by plasma spraying or sintering of Ti particles, present a 
particular surface topography combining an increased surface roughness for improved initial implant 
stability with the potential to achieve long-term stability through mechanical interlocking at the 
implant/bone interface by bone ingrowth into the pores. The eventual bone anchorage, however, 
strongly depends on the quality (amount and interconnectivity) of osseointegration into the porous 
structure. This is primarily determined by the pore characteristics of the coating. Highly porous and 
interconnected open-cell structures favour bone ingrowth and the optimal pore size is generally 
accepted to be in the 100–400 μm range as a compromise to provide sufficient space for cell 
migration and vascularization, while maintaining the mechanical strength of the porous material [14], 
[15] and [16]. 
Modification of the Ti surface to improve the osseointegration of dense implants is well established; 
several recent studies have confirmed the beneficial effect of nanostructured surfaces [17] or CaP 
[18] and [19], calcium silicate and calcium titanate [20] based coatings whether or not doped with 
bioactive ions [21], [22] and [23] on bone formation. Surface modification of the internal pore 
surface of porous Ti constructs has been limited mostly to macroporous Ti scaffolds, showing an 
improved bone ingrowth after sand blasting and/or acid etching [24], acid–alkali treatment [25], 
coating with CaP [26] or hydroxyapatite [27] or preparation of nanostructured calcium titanate and 
titanium oxide surfaces [28]. 
Recently, we developed a new processing route for porous Ti coatings with predominantly micropore 
sizes [29]. Few studies have considered the possible effect of microporosity (0.5–10 μm) on 
osseointegration and only recently research on CaP has shown that micropores in scaffold struts can 
be employed as additional space for bone ingrowth [30], [31] and [32]. Therefore, the first objective 
of the present study was to assess the early peri-implant tissue response to porous pure Ti coatings 
with significant microporosity. Secondly, it was hypothesized that biofunctionalization of the internal 
pore surface could improve the bone regeneration in the vicinity of the coatings. However, when 
envisaging the modification of the internal surface of a porous coating, direct line-of-sight 
techniques, such as plasma spraying, are not qualified. Wet chemical techniques based on a solution 
penetrating the entire porous structure are more suitable [9]. We proposed three wet chemical 
techniques for the application of an additional surface layer in the porous structure. Anatase TiO2, 
which is known to enhance the bioactivity of Ti [33], was applied by a hydrothermal treatment (HT) 
[34]. Furthermore, micro-arc oxidation (MAO) was used to produce a TiO2 surface layer containing 
Ca2+ and PO43− ions [35]. Previous studies have shown that MAO coatings enhance the bone 
response for flat Ti substrates [36], especially when Ca2+ and PO43− ions are incorporated in the 
surface layer [37] and [38]. Alternatively, Ca2+ and PO43− ions can also be introduced in the form of 
dissolution products released from a bioactive glass (BAG) matrix [39]. Both melt and sol–gel-derived 
BAGs have proven to support bone bonding in vivo, but especially sol–gel BAG is associated with 
osteogenesis due to an increased release of ionic species from its intrinsically higher surface area 
[40] and [41]. Moreover, as sol–gel synthesis is more compatible with the coating of porous 
structures, this was the preferred processing route in this study [42]. Coated Ti implants were 
inserted in the rabbit tibia, applying a bone cavity model featuring a regeneration compartment [43]. 
Histological and histomorphometrical analysis of the bone response after 2 and 4 weeks was done 
using transmission light microscopy (LM) and scanning electron microscopy (SEM). 
2. Materials and methods 
2.1. Materials and characterization 
As substrate material, commercially pure Ti (thickness 1 mm, grade 2, Goodfellow) was laser cut into 
discs 15.5 mm in diameter for the surface characterization and discs 4 mm in diameter as implant 
material for the in vivo experiment. Next, the discs were decontaminated by ultrasonically cleaning in 
acetone (Acros Organics) and rinsing in distilled water followed by acid etching in a 4 vol.% HF (40%, 
Riedel-de Haën) and 20 vol.% HNO3 (60%, Chemlab) solution for 60 s. After excessive rinsing in 
distilled water, the samples were autoclave sterilized. 
As the unmodified reference coating, a porous pure titanium coating was applied using 
electrophoretic deposition (EPD) of titanium hydride (TiH2) powder suspensions followed by 
dehydrogenation and sintering in vacuum, as described elsewhere [29]. The coating will be referred 
to as EPD Ti. Subsequently, this coating was functionalized using three different additional 
treatments. First, a hydrothermal treatment (Jožef Stefan Institute, Slovenia) was applied creating a 
thin microanatase TiO2 layer on the outer and inner surfaces of the porous Ti coating [34]. 
Alternatively, MAO (University of Bayreuth, Germany) was used to produce a pore filling TiO2 layer 
containing Ca2+ and PO43− ions [35]. Finally, a micrometer-thin bioactive glass coating was applied 
on the internal surface of the Ti coating using an all-alkoxide sol–gel synthesis (KU Leuven, Belgium) 
[42]. The samples are denominated EPD Ti + HT, EPD Ti + MAO and EPD Ti + BAG, respectively. Prior 
to implantation, the samples were sterilized either using an autoclave (EPD Ti and EPD Ti + HT) or by 
heating to 200 °C in a vacuum furnace (EPD Ti + MAO and EPD Ti + BAG) in order to avoid dissolution 
of the functionalized coatings. 
White light interferometry (WLI, Wyko NT 3300 Optical Profiler, Veeco Metrology Inc.) was used to 
obtain three-dimensional (3-D) roughness measurements. Ten spots divided over three different 
samples were measured per experimental surface. A quantitative analysis of the roughness data was 
performed using MountainsMapH Premium software (Digital Surf). Further qualitative analysis of the 
surface roughness was done by SEM (XL30-FEG, FEI). 
The main pore structure characteristics (porosity, pore size, interconnecting pore channel (IPC) size) 
was done by mercury intrusion porosimetry (MIP, AutoPore IV 9500, Micromeritics) in combination 
with image analysis (PPM2OOF software, NIST) on SEM images of representative metallographic 
cross-sections. 
2.2. Surgical procedure and tissue processing 
The animal handling and experimental protocol used in this study was approved by the Animal Ethics 
Committee of KU Leuven and was performed according to the Belgian national legislation concerning 
the protection and wellbeing of animals. (Approval ID: P122/2008) 
Six mature New Zealand white rabbits (average weight 3.17 ± 0.18 kg) underwent surgery as 
described elsewhere [43]. In short, following anaesthesia, four double-stepped cavities were drilled 
exclusively in the cortical bone of the diaphysis at the medial side of the proximal tibia. The outer 
step diameter was 4 mm in size for a press-fit mounting of the coated implants; the smaller inner 
cavity was 2 mm in diameter with a depth of 0.5 mm (Fig. 1a). To ensure a standardized blood supply 
to the cavity during healing, a perforation (0.5 mm diameter) to the bone marrow was made into the 
base of the cavity centre. Next, the sterilized implants were positioned into the outer cavity and 
covered by a Ti osteosynthesis plate fixed on the cortical bone by means of two Ti osteosynthesis 
screws (Nobel Biocare), to ensure a stable fixation of the implants. Each rabbit received a reference 
coated implant and the three functionalized coated implants, but only for one of both tibiae. After a 
healing period of 2 weeks, the above procedure was repeated for the other tibia, again allowing a 
healing period of 2 weeks. Both healing periods were randomly attributed to the left or right tibia of 
each animal, as were the sites of the various samples within the tibia. 
 Fig. 1.  
Schematic cross-section of (a) the implantation site and (b) the implant/bone assembly for 
histomorphometrical analysis. (c) BSE-SEM micrographs of representative cross-sections of EPD Ti, EPD Ti + HT, 
EPD Ti + MAO and EPD Ti + BAG respectively prior to implantation, and (d) the cumulative intrusion volume as a 
function of pore size as measured by mercury intrusion porosimetry. 
 
Two weeks after the second surgery, the animals were euthanized and the tissues were further 
processed for analysis. The tibiae were dissected out and cut into bone blocks containing one 
implant. These blocks were fixed in a CaCO3 (p.a., VWR International) buffered formalin (35%, VWR 
International) solution during 3 days, dehydrated in a graded series of ethanol over 15 days and 
embedded in a methylmethacrylate (99.5%, VWR International) solution (containing 0.018% benzoyl 
peroxide as a catalyst) over 14 days at room temperature. Next, the bone blocks were cut 
longitudinally and perpendicular to the implant surface using a diamond saw (Leica SP 1600, Leica 
Microsystems). The two most central sections of each implant were taken and prepared for either 
LM or SEM analysis. Sections were ground to a final thickness of ∼30 μm using a micro-grinding 
system (Exakt 400 CS, Exakt) with an 800 grit SiC grinding paper (Hermes). To visualize both the 
mineralized bone and soft tissues using LM, the sections were surface stained with Stevenel’s blue 
and counterstained with Von Gieson’s picrofuchsin. For SEM analysis, the sections were further 
ground using a semi-automatic polishing machine (Pressair TF250, Jean Wirtz) with a 4000 grit SiC 
grinding paper (Hermes), followed by polishing with 3 μm diamond particles (Diapat S, VEM 
Metallurgie) on a neoprene cloth (OP-Chem, Struers). 
2.3. Methods of analysis 
The bone cavity model was the same as used by Chaudhari et al. [43]; Fig. 1b shows a schematic 
representation of a cross-sectioned implant/bone assembly. There are two main regions of interest, 
i.e., the central cavity, denominated as “bone regeneration area (BRA)”, which is a region without 
any bone at the time of implantation and allows an investigation of the bone regeneration potential 
of the coating, and the periphery, the “bone adaptation area (BAA)”, where the implant is initially in 
contact with the bone at the time of implantation and which allows the bone response in direct 
contact with the coating to be observed. 
For a descriptive histological evaluation of the bone response, the surface stained sections were 
examined using LM. In addition, a quantitative histomorphometrical analysis was performed using 
image analysis software (Axiovision 4.0, Zeiss) with customized scripts for semi-automatic analysis. 
All analyses were performed by the same operator, who was blinded for the sample composition. As 
a measure for the bone regeneration potential, the bone area fraction (BAF), i.e. the percentage of 
the BRA occupied by newly formed bone trabeculae (BT), taking into account either the whole BRA 
cavity (BAF-500, in %), that part of the BRA within 100 μm from the implant (BAF-100, in %) or that 
part of the BRA at a distance of 100–500 μm from the implant (BAF-400, in %). To rule out any 
variability in bone density between different animals or even different positions in the cortical bone, 
all BAF parameters were considered proportional to the bone density measured in the reference 
areas (RA), well-defined areas next to the trauma zone reflecting the bone’s natural density. In 
addition, the bone-to-implant contact ratios in the BAA (BIC-BAA, in %) or BRA (BIC-BRA, in %), were 
calculated as the percentage of the BAA length, respectively BRA length, in direct contact with bone. 
For the exact mathematical formulas, we refer to previous work [43]. 
Because the thickness of histological sections (∼30 μm) is comparable to the pore size range of the 
EPD Ti coatings (2–50 μm), the coating’s pore structure with or without ingrowth of bone cannot be 
representatively depicted by transmission LM due to projection artifacts. A surface-sensitive 
analytical technique such as SEM is preferred. Following gold coating with a sputtering device 
(Edwards S150), all samples were analysed with backscattered electron (BSE) imaging using the same 
operating conditions (10 mm working distance, 20 kV accelerating voltage) and image settings 
(contrast, brightness). Additionally, elemental analysis was done by SEM with associated energy 
dispersive X-ray spectroscopy (EDS, EDAX), while elemental mapping was performed using electron 
microprobe microanalysis (EPMA, JXA-8503F, JEOL Ltd) with associated wavelength dispersive X-ray 
spectroscopy (WDS). As histomorphometrical parameter, the percentage of the available pore area 
occupied by newly formed bone, i.e. the bone ingrowth fraction (BIF, in %), was determined by image 
analysis (CTAn, SkyScan NV). Validation of this protocol for histomorphometrical analysis was done 
by comparing the results for BAF-500 obtained by both LM and SEM (R2: 0.9826). 
2.4. Statistical analysis 
Significant differences (P < 0.02) in roughness and pore characteristics were identified by an unpaired 
Student’s t-test using statistical analysis add-in software for Microsoft Excel® (Analyse-it® version 
2.26, Analyse-it Software Ltd). The validity of the test was verified by checking the normality of 
distribution (Shapiro–Wilk). The equality of variances was investigated using an F-test (P < 0.05) and 
in the case of unequal variances, a Welch’s correction was applied to the t-test. 
Statistical analyses of the histomorphometrical parameters were performed with SAS 9.2 (SAS 
Institute Inc.). Because of the clustered nature of the data, a mixed statistical model considering both 
fixed effects (implant type and implant/time interaction) and random effects (animal) was applied. 
Normality of the data and homogeneity of the residuals were checked by diagnostic plots and if 
necessary, data were transformed to meet both requirements. The proc mixed option in SAS allowed 
to calculate the differences between implants for a certain healing period as well as the evolution 
over time (2 to 4 weeks) for a given implant type (P < 0.05 was considered to be statistically 
significant). 
3. Results 
3.1. Coating characterization 
A quantitative 3-D topographical analysis (Table 1) was performed by the calculation of average 
roughness (Sa, amplitude parameter), texture aspect ratio (Str, spatial parameter) and developed 
interfacial area ratio (Sdr, hybrid parameter). Sa was comparable for all coatings in the absence of a 
directional structure (Str), whereas the surface area decreased when applying MAO or BAG coatings 
on EPD Ti. Representative cross-sections of the different coatings obtained by SEM ( Fig. 1c) allowed 
us to calculate the overall porosity ( Table 1), while the cumulative intrusion volume as obtained by 
MIP allowed us to establish an IPC size distribution ( Fig. 1d). HT and BAG treatments did not 
significantly alter the original EPD Ti porosity value of ∼50% and also the IPC size distribution was 
fairly comparable to EPD Ti, especially for the bulk pores (<10 μm). For the pore size range from 300 
down to 10 μm, which can mainly be associated with the surface pores, the pore size distribution for 
EPD Ti + HT indicated a larger fraction of pores, probably due to surface cracks present in those 
samples. The strong deviation seen for EPD Ti + BAG at low pore sizes (<0.1 μm) was most probably 
due to an undesirable reaction between the Hg and the BAG during analysis, forming amalgams with 
several metals, as there is sodium [44]. MAO treatment on the other hand introduced a pore-filling 
Ti-oxide phase (grey phase in Fig. 1c), reducing the porosity to 28.0%. This was mainly reflected by a 
reduction of the bulk pore size shifting to the submicrometer range. 
Table 1.  
Surface roughness parameters of the different coatings measured by white light interferometry 
[29] and [52] (values represent mean ± SD). 
 Sa (μm) Str (−) Sdr (%) Porosity (%) 
EPD Ti 4.5 ± 0.4 0.6 ± 0.1 61.7 ± 15.4 51.2 ± 3.9 
EPD Ti + HT 4.9 ± 2.0 0.7 ± 0.1 56.9 ± 27.2 45.9 ± 1.0 
EPD Ti + MAO 4.3 ± 0.2 0.8 ± 0.1 35.6 ± 9.9a 28.0 ± 3.8a 
EPD Ti + BAG 4.3 ± 1.6 0.8 ± 0.1 40.5 ± 11.1a 51.3 ± 3.4 
Sa = Roughness average, arithmetic mean of the absolute values of the surface departures from the mean 
plane. 
Str = Texture aspect ratio, measure for the texture strength: values >0.5 suggest an isotropic texture; values 
<0.3 indicate a directional structure. 
Sdr = Developed interfacial area ratio, percentage of additional surface area as compared to an ideal plane the 
size of the sampling area. 
a Statistically significant differences with the unmodified EPD Ti surface. 
 
3.2. Clinical observation 
All rabbits remained in good health for the whole duration of the healing period. During implant 
retrieval, no clinical signs of infection or adverse tissue reaction were observed around the surgical 
site. In total, 48 implants were harvested and considered for further analysis. 
3.3. Histology 
Fig. 2 displays representative features of the tissue response after both 2 and 4 weeks of 
implantation obtained by LM. After 2 weeks of implantation (Fig. 2a and b), a non-organized 
connective tissue comprising osteoblast-like cells, adipocytes and accumulations of blood cells was 
observed as well as well-organized tissue consisting of blood cells organized into blood vessels, 
clusters of cuboidal shaped (i.e. active) osteoblast cells surrounded by osteoid deposition in 
connection with mineralized bone trabeculae. After 4 weeks (Fig. 2c), the bone trabeculae became 
more dense with smaller osteocyte lacunae and were covered with a row of active osteoblasts, 
suggesting an active bone formation process. Simultaneously, Fig. 2d depicts a multinucleated 
osteoclast at the interface between implant and original cortical bone in the BAA, demonstrating a 
process of bone resorption. This was found to be more pronounced after 4 than after 2 weeks of 
implantation. 
 Fig. 2.  
Detailed light micrographs of representative features of the histological observations: (a and b) non-organized 
connective tissue comprised of adipocytes (A), osteoblast-like cells and blood cells together with well-organized 
tissue of blood vessels (BV), active osteoblasts (OB) depositing osteoid (O) and mineralized bone (MB) after 
2 weeks of implantation; (c) active OB lined up along dense MB and (d) multinucleated osteoclast (OC) at the 
interface between implant (I) and original cortical bone, illustrating bone remodelling, after 4 weeks of 
implantation. 
 
Since visualization of bone in or in close contact with the microporous Ti coatings at high 
magnification was not possible using LM (due to projection artifacts) or X-ray computed tomography 
(due to scatter artifacts), BSE-SEM images were taken. As BSE images depict an atomic number 
contrast, the Ti implant and coating appeared bright (white), while the mineralized bone was grey. 
Discrimination between the low density organic soft tissue and the embedding medium was not 
possible using BSE and these materials are viewed as black areas. Observations of the mineralized 
bone trabeculae in the BRA above the Ti coatings were in accordance with LM. At 2 weeks, bone 
trabeculae were irregular and highly cellular, i.e., with a high proportion of osteoblast lacunae, 
whereas the bone trabeculae after 4 weeks occupied a larger part of the BRA and had become larger 
and more dense, i.e. smaller osteoblast lacunae (results not shown). In general, bone ingrowth into 
the coatings after 2 weeks was limited to the colonization of the open surface pores (Fig. 3a), 
although a low-mineralized tissue could be seen throughout the whole coating thickness in some 
samples (Fig. 3b). 
Fig. 3.  
(a and b) Representative BSE-SEM micrographs of a porous Ti coating cross-section after 2 weeks of 
implantation, indicating (a) limited bone ingrowth at the coating surface and (b) the presence of a low-
mineralized phase throughout the whole coating. (c–f) Representative BSE-SEM micrographs of (c) EPD Ti, (d) 
EPD Ti + HT, (e) EPD Ti + MAO and (f) EPD Ti + BAG after 4 weeks of implantation, showing bone ingrowth up to 
the substrate/coating interface, except for EPD Ti + MAO. (g) BSE-SEM micrograph and associated WDS 
elemental mappings for Ti (blue), Ca (red), Si (green) of EPD Ti + BAG after 4 weeks of implantation. (h) 
Binarized BSE-SEM micrograph for EPD Ti after 4 weeks of implantation. 
 
Fig. 3c–f shows representative BSE-SEM micrographs of cross-sections of the different coatings in 
contact with the BRA after 4 weeks of implantation. For EPD Ti + HT + BAG, the grey phase present 
throughout the whole coating (white) up to the coating/substrate interface was confirmed to be 
bone (with a Ca/P ratio of ca. 1.6) by EDS point analyses. Note that also osteocyte lacunae could be 
observed inside the coating. For EPD Ti + MAO, elemental analysis assigned the observed grey phase 
to a phosphated TiO2 phase which was already present prior to implantation (Fig. 1c). No significant 
differences in porosity, as determined by image analysis, could be observed between 2 and 4 weeks 
of implantation, indicating that no or only slow dissolution of the TiO2 phase had occurred. 
For the EPD Ti + BAG coatings, traces of an additional grey phase, containing Si with small amounts of 
P, Ca and Na, were observed, pointing at the presence of partially dissolved BAG. To determine to 
what extent BAG was still remaining after implantation, a WDS elemental mapping was performed on 
a coating after 4 weeks of implantation (Fig. 3g). While Ca and P were the main composing elements 
of the prominent grey phase observed by BSE-SEM, Si (and thus BAG) was mainly detected as a thin 
layer at the coating surface (top) and coating/substrate interface (bottom), in contact with the new 
bone phase. 
Additionally, the growth pattern of the bone trabeculae inside the porous coatings was visualized by 
binarizing BSE-SEM images in order to convert the bone phase to white and all other phases including 
the implant to black. A representative EPD Ti reference coating after 4 weeks of implantation is 
shown in Fig. 3h. This again confirmed that bone was present throughout the whole coating 
thickness, and also showed that bone appeared in the form of trabeculae, which are interconnected 
with the bone trabeculae in the BRA above or surrounding cortical bone inside the porous structure. 
3.4. Histomorphometry 
Fig. 4 summarizes the results of the histomorphometrical analysis. The fraction of newly formed 
bone with respect to the entire BRA, BAF-500 (Fig. 4a), tended to increase with implantation time for 
all functionalized coatings in comparison to the reference coating. However, a statistically significant 
difference was only observed for the EPD Ti + HT and EPD Ti + BAG between 2 and 4 weeks and more 
importantly when comparing EPD Ti + BAG (61.8 ± 5.6%) with the EPD Ti reference (36.3 ± 8.6%) at 
4 weeks. In the vicinity of the implant, the effect of implantation time was more pronounced (BAF-
100, Fig. 4b), but no significant differences could be seen among the various coatings. BAF-100 after 
4 weeks was significantly higher than BAF-400 (Fig. 4c) for EPD Ti (49.8 ± 8.6% vs. 33.1 ± 9.0%) and 
EPD Ti + MAO (65.1 ± 7.0% vs. 45.9 ± 10.9%), whereas it was significantly lower than BAF-400 for EPD 
Ti + BAG (50.4 ± 4.5% vs. 64.8 ± 7.2%). A trend of increased BIC-BRA between 2 and 4 weeks of 
implantation can was observed, except for EPD Ti + BAG, for which the BIC-BRA at 4 weeks was 
significantly lower than for other conditions (Fig. 4d). As the bone remodelling cycle in the rabbit 
takes up to 6 weeks [45], the results for the BIC-BAA 2 and 4 weeks following implantation (data not 
shown) did not allow us to discriminate between the different coatings. 
 Fig. 4.  
Bone histomorphometrical parameters: bone area fraction (BAF) (a) with respect to the entire bone 
regeneration area (BRA), BAF-500, or (b) with respect to the part of the BRA within 100 μm of the implant, BAF-
100, or (c) with respect to the part of the BRA within 100 to 500 μm away from the implant, BAF-400, (d) bone-
to-implant contact (BIC) in the BRA and (e) bone ingrowth fraction (BIF) in the different porous Ti coatings. 
Results are presented as mean values ± standard errors; statistically significant (P < 0.05) differences are 
indicated by the horizontal lines. ∗ and ● indicate statistically significant (P < 0.05) differences between BAF-
100 and BAF-400 for the same coating and implantation time. 
 
The BIF, i.e. new bone established inside the porous Ti coating, tended to increase over time, except 
for EPD Ti + MAO, where no bone ingrowth was observed (Fig. 4e). However, for a specific 
implantation period, no differences could be observed among the various conditions. 
4. Discussion 
Porous Ti coated implants have already been successfully applied in both orthopaedics and dentistry 
[3], [46], [47], [48] and [49]. However, in certain specific circumstances such as the application in 
compromised bone or in revision surgery, the fixation results are still suboptimal [50]. Additionally, 
higher patient demands, such as an improved implant durability and longevity for younger patients 
and/or a reduced recovery period, necessitate a progressive increase in quality and speed of 
osseointegration. 
Current clinically applied porous Ti coatings are mainly limited to coatings obtained by plasma 
spraying techniques, such as vacuum plasma spraying (VPS). These coatings benefit from a moderate 
to high surface roughness (a few μm up to 100 μm), allowing a good retention in the host bone, but 
possess an irregular porosity distribution and limited pore interconnectivity [15] and [51]. In the 
context of bone ingrowth, these coatings should mostly be considered as roughened surfaces rather 
than porous coatings. In contrast, porous Ti coatings obtained by powder sintering can be fully 
interconnected with a well-controlled porosity [15]. The porous Ti coatings used in this study 
combine an increased porosity with a good mechanical strength, while significantly reducing the risk 
of biofilm formation as compared to VPS Ti coatings [29] and [52]. However, the predominantly 
microporous structure (Fig. 1d) rendered their potential for bone ingrowth applications uncertain, as 
the general consensus in literature is on a minimal pore size of 50 to 100 μm [14], [15] and [16]. Bone 
ingrowth in micropores (0.5–10 μm) [30] has only been addressed in a limited number of studies. For 
CaP materials, for example, although the presence of micropores has been reported earlier to 
positively influence bone formation in macropores [30], [53], [54] and [55], Levengood et al. were the 
first to exploit microporosity as additional space for bone ingrowth [30]. For titanium, the focus is still 
on macroporosity, but bone ingrowth in pores down to 50 μm has been demonstrated [56], 
[57] and [58]. However, it should be noted that studies often only cite the average pore size, while it 
is actually the smaller IPC size that limits bone ingrowth. Baril et al. recently found that bone 
ingrowth in porous Ti structures appeared for interconnective sizes as small as 28 μm [59]. The 
observation of bone growth into the microporous coatings presented in this study (Fig. 3) extends 
this lower limit further to the microporosity size range below 10 μm. Bone and even osteocytes 
embedded in a mineralized matrix are present in the micropores, similarly to what Levengood et al. 
reported for CaP scaffolds [30]. This can be observed for chemically modified EPD Ti as well as for the 
unmodified reference coating, indicating that osteogenic cells migrated through the microporous Ti 
structure and produced mineralized tissue even in the absence of a surface modification. Visualizing 
the patterns of bone ingrowth (Fig. 3h) revealed that the bone grows as trabeculae through the 
microporous structure, interwoven with the pore struts. This leads to a strong increase in contact 
area, which may lead to a more uniform load transfer and a stronger implant/bone interface. 
Moreover, the ingrown bone was clearly interconnected with the surrounding cortical bone, 
confirming the possibility of mechanical interlocking of the implant in the host bone tissue. As the 
coating thickness was less than 200 μm, it is likely that bone cells inside the porous structure 
remained close enough to a vascular supply in the surrounding bone tissue to retain access to 
nutrients and expel waste [30]. This could also explain the discrepancy with the literature consensus 
on a 100 μm minimal pore size. Generally, the focus in bone regeneration research has been on 
larger porous structures (>200 μm) such as scaffolds, where macroporosity is indeed required for 
vascularization. 
In addition to assessing the possibility of bone ingrowth in microporous Ti coatings, the second 
objective of this study was to investigate the effect of surface modifications on bone healing around 
and inside the porous coatings. In order to modify the internal surface of the microporous Ti 
coatings, three wet chemical techniques were selected which are known to enhance bone response 
on dense Ti substrates. 
Histological observations confirmed the presence of normal bone healing patterns for all coatings. 
Bone regeneration in the BRA evolved from unorganized connective tissue (Fig. 2a) over osteoid 
depositing osteoblasts to newly formed bone trabeculae aligned with active osteoblasts (Fig. 2b and 
c), while osteoclast activity in the BAA after 4 weeks (Fig. 2d) indicated bone remodelling, an 
elementary phase of osseointegration. Both size and density of the bone trabeculae increased with 
implantation time (Fig. 2c), an observation that was supported by the histomorphometrical results 
(Fig. 4a–c). Increased bone regeneration in the BRA, which is insignificant for HT and MAO coatings, 
could be observed for BAG coatings when compared to the unmodified EPD Ti coating (Fig. 4a), 
confirming the osteogenic potential of this sol–gel-derived glass–ceramic coating. However, similarly 
to what has been observed for a melt-derived glass–ceramic coating [43], this enhanced bone 
regeneration was due to an increased bone fraction further away from the surface (BAF-400) rather 
than at the implant surface (BAF-100) (Fig. 4b and c). In relation to this, the BIC-BRA was significantly 
lower for EPD Ti + BAG when compared to EPD Ti. The bioactive nature of BAG is related to its 
gradual dissolution in contact with physiological fluids, which induces osteoconduction by the 
formation of a HCA layer on the surface and promotes osteoinduction by the leaching of degradation 
products [41] and [60]. It has been shown that the ionic degradation products of sol–gel-derived BAG 
have a beneficial effect on osteoblasts [40]. However, this ion leaching (cations such as Ca2+ and 
Na+) has also been found to increase the interfacial pH, which was suggested to decrease cell 
attachment [41] and [61]. This may explain the improved BAF-500, in combination with a limited BIC-
BRA. 
Bone ingrowth after 2 weeks remained limited to the open surface pores, whereas bone was found 
throughout the whole coating thickness up to the coating/substrate interface for EPD Ti + HT or BAG 
after 4 weeks (Fig. 3), similarly to what was observed for the unmodified EPD Ti reference coating. 
BIF slightly increased with the duration of implantation, but did not allow us to discriminate between 
the different surface modifications. This was in line with the results for bone regeneration close to 
the implant surface (BAF-100), which was similar for the EPD Ti reference coating before and after HT 
or BAG treatment. Within the short time frame of this study, these surface modifications did not 
seem to contribute to a significantly improved bone ingrowth into the porous Ti coatings. However, it 
is to be noted that prolonged in vivo experiments should be implemented to further elucidate the 
effect on the eventual osseointegration, especially in the case of BAG, since a faster bone 
regeneration around the coating was clearly established. For EPD Ti + MAO, no bone was observed 
inside the pores, which only contained the original pore filling TiO2 phase (Fig. 3c). This is explained 
by the differences in pore characteristics (Fig. 2c and d). Whereas for EPD Ti + HT or BAG the IPC size 
range was comparable to that of the unmodified EPD Ti coating, it was shifted towards the 
submicrometer level for EPD Ti + MAO, which is probably too small to allow colonization by 
osteoblasts. This emphasizes the importance of a surface modification which does not drastically 
alter the pore structure of the coatings. 
5. Conclusion 
The experimental data demonstrated that bone cells populate the pore structure of the experimental 
EPD Ti coatings, enabling bone ingrowth into the pores. This shifts the lower threshold value for pore 
sizes, allowing bone ingrowth towards the microporosity range below 10 μm. Moreover, the bone 
trabeculae were strongly interwoven with the pore struts and the well-established interconnections 
with the surrounding cortical bone suggest that micro-interlocking of the porous coating is possible, 
which can be a major advantage for the long-term stability of implants. When envisaging surface 
modifications to further improve the osteoconductivity of the porous Ti, pore sizes should not be 
further reduced, as this would obstruct bone ingrowth, as could be observed after MAO of the 
porous Ti. It is therefore advisable that the processing parameters are fine-tuned in order to 
minimize the effect on the pore characteristics. 
A sol–gel-derived bioactive glass–ceramic in the inner pore surface of the EPD Ti coating, which did 
not alter the pore structure, was shown to allow bone ingrowth comparable to the unmodified 
reference, while significantly increasing the bone regeneration around the porous coatings. The 
bone-to-implant contact, however, was reduced, indicating the necessity of tuning the BAG surface 
properties. Similarly, hydrothermal treatment did not interfere with bone ingrowth in the porous Ti 
coating; however, no significant improvement in bone regeneration was observed. 
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Appendix A. Figures with essential colour discrimination 
Certain figures in this article, particularly Figs. 1–3, are difficult to interpret in black and white. The 
full colour images can be found in the on-line version, at 
http://dx.doi.org/10.1016/j.actbio.2013.10.017. 
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